Dashboard
Manage Tickers

CGTXCOGNITION THERAPEUTICS INC

Nasdaq cogrx.com


$ 1.98 $ 0.02 (1.04 %)    

Friday, 26-Apr-2024 15:07:24 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 1.95
$ 1.96
$ 0.00 x 0
$ 0.00 x 0
$ 1.92 - $ 1.98
$ 0.90 - $ 3.49
55,056
na
58.56M
$ 1.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-26-2024 12-31-2023 10-K
2 11-02-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 03-23-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-11-2022 03-31-2022 10-Q
9 03-30-2022 12-31-2021 10-K
10 11-17-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
04/22/2024 20:31:12

b-riley-securities-reiterates-buy-on-cognition-therapeutics-maintains-5-price-target
B. Riley Securities Reiterates Buy on Cogn...
03/28/2024 15:58:29

B. Riley Securities analyst Mayank Mamtani reiterates Cognition Therapeutics (NASDAQ:CGTX) with a Buy and maintains $5 price...

oppenheimer-maintains-outperform-on-cognition-therapeutics-maintains-9-price-target
Oppenheimer Maintains Outperform on Cognit...
03/27/2024 11:34:27

Oppenheimer analyst Jay Olson maintains Cognition Therapeutics (NASDAQ:CGTX) with a Outperform and maintains $9 price target.

cognition-therapeutics-q4-eps-027-beats-034-estimate
Cognition Therapeutics Q4 EPS $(0.27) Beat...
03/26/2024 13:28:25

Cognition Therapeutics (NASDAQ:CGTX) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate o...

cognition-therapeutics-reports-fy23-net-loss-per-share-of-086-compared-with-091-yoy-cash-and-equivalents-as-of-december-31-2023-were-approximately-299m
Cognition Therapeutics Reports FY23 Net Lo...
03/26/2024 11:10:27

earnings-scheduled-for-march-26-2024
Earnings Scheduled For March 26, 2024
03/26/2024 08:47:27

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on reve...

a-preview-of-cognition-therapeuticss-earnings
A Preview Of Cognition Therapeutics's Earn...
03/25/2024 15:01:20

cognition-therapeutics-and-2-other-stocks-under-2-insiders-are-buying
Cognition Therapeutics And 2 Other Stocks ...
03/15/2024 11:13:55

The Dow Jones index closed lower by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their...

reported-earlier-cognition-therapeutics-prices-115m-public-offering-of-6571428-common-shares-at-175share
Reported Earlier, Cognition Therapeutics P...
03/12/2024 06:55:23

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
03/11/2024 21:34:44

cognition-therapeutics-announces-proposed-public-offering-of-common-stock-terms-not-disclosed
Cognition Therapeutics Announces Proposed ...
03/11/2024 20:09:19

cognition-therapeutics-announces-new-publication-identifying-key-proteins-involved-in-amyloid-oligomer-binding-and-supports-mechanism-of-ct1812
Cognition Therapeutics Announces New Publi...
02/06/2024 13:48:20

Cognition Therapeutics, Inc. (NASDAQ:CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, a...

why-airspan-networks-shares-are-trading-higher-by-over-380-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Airspan Networks Shares Are Trading Hi...
01/17/2024 18:12:57

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announ...

cognition-therapeutics-filed-us-patent-application-20240009-compositions-for-treating-dry-age-related-macular-degeneration-amd
Cognition Therapeutics Filed U.S. Patent A...
01/11/2024 15:07:20

https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20240009168

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
01/04/2024 21:31:07

cognition-therapeutics-has-received-a-notice-of-allowance-for-its-us-patent-application-17537110-titled-compositions-for-treating-neurodegenerative-diseases-including-alzheimers-disease-and-cognitive-decline
Cognition Therapeutics Has Received A Noti...
01/04/2024 17:41:11

https://patentcenter.uspto.gov/applications/17537110/ifw/docs

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
12/11/2023 17:30:56

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
12/04/2023 21:31:08

cognition-therapeutics-presents-preclinical-data-identifying-pathways-impacted-by-sigma-2-receptor-modulators-in-alzheimers-and-parkinsons-diseases
Cognition Therapeutics Presents Preclinica...
11/15/2023 12:33:47

 Cognition Therapeutics, Inc. (NASDAQ:CGTX) is presenting in vivo preclinical results at the Society for Neuroscience's ann...

cognition-therapeutics-completes-enrollment-in-phase-2-shine-study-of-ct1812-in-mild-to-moderate-alzheimers-disease
Cognition Therapeutics Completes Enrollmen...
11/07/2023 12:37:58

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION